ENCOMPASS HEALTH CORPORATIONENCOMPASS HEALTH CORPORATIONENCOMPASS HEALTH CORPORATION

ENCOMPASS HEALTH CORPORATION

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪191.78 B‬MXN
94.46MXN
‪9.44 B‬MXN
‪112.03 B‬MXN
‪99.14 M‬
Beta (1Y)
0.65
Employees (FY)
‪40 K‬
Change (1Y)
‪+2.24 K‬ +5.93%
Revenue / Employee (1Y)
‪2.80 M‬MXN
Net income / Employee (1Y)
‪237.53 K‬MXN

About Encompass Health Corporation


CEO
Mark J. Tarr
Headquarters
Birmingham
Founded
1984
FIGI
BBG00NJCYKY3
Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
EHC4343864
Encompass Health Corporation 5.75% 15-SEP-2025
Yield to maturity
5.93%
Maturity date
Sep 15, 2025
EHC5055661
Encompass Health Corporation 4.625% 01-APR-2031
Yield to maturity
5.89%
Maturity date
Apr 1, 2031
EHC4882392
Encompass Health Corporation 4.75% 01-FEB-2030
Yield to maturity
5.67%
Maturity date
Feb 1, 2030
EHC4882391
Encompass Health Corporation 4.5% 01-FEB-2028
Yield to maturity
5.61%
Maturity date
Feb 1, 2028

See all EHC bonds 



Frequently Asked Questions


The current price of EHC is 1,037.98 MXN — it has decreased by −2.52% in the past 24 hours. Watch ENCOMPASS HEALTH CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange ENCOMPASS HEALTH CORPORATION stocks are traded under the ticker EHC.
We've gathered analysts' opinions on ENCOMPASS HEALTH CORPORATION future price: according to them, EHC price has a max estimate of 2,573.87 MXN and a min estimate of 2,265.01 MXN. Watch EHC chart and read a more detailed ENCOMPASS HEALTH CORPORATION stock forecast: see what analysts think of ENCOMPASS HEALTH CORPORATION and suggest that you do with its stocks.
EHC reached its all-time high on May 19, 2020 with the price of 1,375.70 MXN, and its all-time low was 920.99 MXN and was reached on Mar 7, 2019. View more price dynamics on EHC chart.
See other stocks reaching their highest and lowest prices.
EHC stock is 2.59% volatile and has beta coefficient of 0.65. Track ENCOMPASS HEALTH CORPORATION stock price on the chart and check out the list of the most volatile stocks — is ENCOMPASS HEALTH CORPORATION there?
Today ENCOMPASS HEALTH CORPORATION has the market capitalization of ‪197.29 B‬, it has increased by 1.18% over the last week.
Yes, you can track ENCOMPASS HEALTH CORPORATION financials in yearly and quarterly reports right on TradingView.
ENCOMPASS HEALTH CORPORATION is going to release the next earnings report on Apr 23, 2025. Keep track of upcoming events with our Earnings Calendar.
EHC earnings for the last quarter are 24.39 MXN per share, whereas the estimation was 21.37 MXN resulting in a 14.16% surprise. The estimated earnings for the next quarter are 24.27 MXN per share. See more details about ENCOMPASS HEALTH CORPORATION earnings.
ENCOMPASS HEALTH CORPORATION revenue for the last quarter amounts to ‪29.29 B‬ MXN, despite the estimated figure of ‪28.80 B‬ MXN. In the next quarter, revenue is expected to reach ‪28.94 B‬ MXN.
EHC net income for the last quarter is ‪2.50 B‬ MXN, while the quarter before that showed ‪2.12 B‬ MXN of net income which accounts for 18.22% change. Track more ENCOMPASS HEALTH CORPORATION financial stats to get the full picture.
Yes, EHC dividends are paid quarterly. The last dividend per share was 3.50 MXN. As of today, Dividend Yield (TTM)% is 0.66%. Tracking ENCOMPASS HEALTH CORPORATION dividends might help you take more informed decisions.
ENCOMPASS HEALTH CORPORATION dividend yield was 0.69% in 2024, and payout ratio reached 14.35%. The year before the numbers were 0.90% and 17.27% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Mar 13, 2025, the company has ‪40.00 K‬ employees. See our rating of the largest employees — is ENCOMPASS HEALTH CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ENCOMPASS HEALTH CORPORATION EBITDA is ‪24.27 B‬ MXN, and current EBITDA margin is 21.66%. See more stats in ENCOMPASS HEALTH CORPORATION financial statements.
Like other stocks, EHC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENCOMPASS HEALTH CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ENCOMPASS HEALTH CORPORATION technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ENCOMPASS HEALTH CORPORATION stock shows the strong sell signal. See more of ENCOMPASS HEALTH CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.